Tetrahydrobiopterin in the prevention of hypertonia in hypoxic fetal brain

Annals of Neurology

Volumn 66, Issue 3, 2009, Pages 323-331

  Vásquez Vivar, Jeannette ^a,b,d   Whitsett, Jennifer ^a   Derrick, Matthew ^c   Ji, Xinhai ^c   Yu, Lei ^c   Tan, Sidhartha ^c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b FREE RADICAL RESEARCH CENTER   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; DOPAMINE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; SEPIAPTERIN; SEROTONIN; TETRAHYDROBIOPTERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN REGION; COGNITION; CONTROLLED STUDY; DISEASE SEVERITY; DYSTONIA; FEMALE; FETUS; FRONTAL CORTEX; HIPPOCAMPUS; INCIDENCE; MOTOR DYSFUNCTION; MUSCLE HYPERTONIA; NEWBORN; NONHUMAN; OCCIPITAL CORTEX; PARIETAL LOBE; PERINATAL DEATH; PERINATAL PERIOD; PRIORITY JOURNAL; RABBIT; THALAMUS; TREATMENT OUTCOME;

ANIMALS; ANIMALS, NEWBORN; BIOPTERIN; BRAIN; BRAIN CHEMISTRY; DISEASE MODELS, ANIMAL; DYSTONIA; FEMALE; FETAL DEVELOPMENT; FETAL HYPOXIA; GESTATIONAL AGE; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; MATERNAL-FETAL EXCHANGE; MUSCLE HYPERTONIA; NITRIC OXIDE SYNTHASE; PREGNANCY; PTERINS; RABBITS;

EID: 70350041395     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21738     Document Type: Article

References (28)

1. Barret RD, Bennet L, Davidson J, et al. Destruction and reconstruction: hypoxia and the developing brain. Birth Defects Res C Embryo Today 2007;81:163-176. (Pubitemid 350086245)
2. Robertson C, Finner N. Term infants with hypoxic-ischemic encephalopathy: outcome at 3,5 years. Dev Med Child Neurol 1985;27:473-484. (Pubitemid 15243414)
3. Ichinose H, Ohye T, Takahashi E, et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 1994;8:236-242. (Pubitemid 24338734)
4. Blau N, Thöny B, Cotton RGH, Hyland K. Disorders of tetrahydrobiopterin and related biogenic amines. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Vogel-Stein B, eds. The Metabolic and Molecular Basis of Inherited Diseases. 8th ed. New York, NY: McGraw-Hill; 2001 pp. 1725-1776.
5. Blau N, Dhondt JL. BIODEF international database of tetrahydrobiopterin deficiencies. Available at: http://www.bh4.org/ BH4DatabasesBiodef.asp Accessed March 15, 2009.
6. Kalkanoglu HS, Romstad A, Coşkun T, Güttler F. Evaluation of a fetus at risk for dihydropteridine reductase deficiency by direct mutation analysis using denaturing gradient gel electrophoresis. Prenat Diagn 2001;21:868-870. (Pubitemid 33064085)
7. Fink JK, Ravin P, Argoff CE, et al. Tetrahydrobiopterin administration in biopterin-deficient progressive dystonia with diurnal variation. Neurology 1989;39:1393-1395. (Pubitemid 19246819)
8. Bode VC, McDonald JD, Guenet JL, Simon D. Hph-1: a mouse mutant with hereditary hyperphenylalaninemia induced by ethylnitrosourea mutagenesis. Genetics 1988;118:299-305. (Pubitemid 18066647)
9. Jinnah HA, Hess EJ, Ledoux MS, Sharma N. Rodent models for dystonia research: characteristics, evaluation, and utility. Mov Disord 2005;20:283-292. (Pubitemid 40613288)
10. Derrick M, Luo NL, Bregman JC, et al. Preterm fetal hypoxia-ischemia hypertonia and motor deficits in the neonatal rabbit: a model for human cerebral palsy? J. Neurosci 2004;24:24-34. (Pubitemid 38181666)
11. Damiano DL, Quinlivan JM, Owen BF, et al. What does the Ashworth scale really measure and are instrumented measures more valid and precise? Dev Med Child Neurol 2002;44: 112-118.
12. Fukushima T, Nixon JC. Analysis of reduced forms of biopterin in biological tissues and fluids. Anal Biochem 1980;102: 176-188. (Pubitemid 10099498)
13. Whitsett J, Picklo MJ Sr, Vasquez-Vivar J. 4-Hydroxy-2- nonenal increases superoxide anion radical in endothelial cells via stimulated GTP cyclohydrolase proteasomal degradation. Arterioscler Thromb Vasc Biol 2007;27:2340-2347. (Pubitemid 350203948)
14. Acworth IN, Cunningham ML. The measurement of monoamine neurotransmitters in microdialysis perfusates using HPLC-ECD. In: Harry J, Tilson HA, eds. Methods in Molecular Medicine. Vol 22 pp. 219-236. Totowa, NJ: Humana Press; 1999.
15. Pieper GM, Nilakantan V, Halligan NL, et al. Nitric oxide formation in acutely rejecting cardiac allografts correlates with GTP cyclohydrolase I activity. Biochem J 2005;391:541-547. (Pubitemid 41634779)
16. Hoshiga M, Hatakeyama K, Watanabe M, Shimada M, Kagamiyama H. Autoradiographic distribution of [14C]tetrahydrobiopterin and its developmental change in mice. J Pharmacol Exp Ther 1993;267:971-978. (Pubitemid 23352562)
17. Canevari L, Land JM, Clarck JB, Heales SJR. Stimulation of the brain NO/cyclic GMP pathway by peripheral administration of tetrahydrobiopterin in the hph-1 mouse. J Neurochem 1999;73:2563-2568.
18. Hasewaga H, Sawabe K, Nakanishi N, Wakasugi OK. Delivery of exogenous tetrahydrobiopterin (BH4) to cells of target organs: role of salvage pathway and uptake of its precursor in effective elevation of tissue BH4. Mol Genet Metab 2005;86: S2-S10. (Pubitemid 41771104)
19. Leeming RJ, Blair JA. The effects of pathological and normal physiological processes on biopterin derivative levels in man. Clin Chim Acta 1980;108:103-111.
20. Lam AA, Hyland K, Heales SJ. Tetrahydrobiopterin availability, nitric oxide metabolism and glutathione status in the hph-1 mouse: implications for the pathogenesis and treatment of tetrahydrobiopterin deficiency states. J Inherit Metab Dis 2007; 30:256-262. (Pubitemid 46488008)
21. Ponzone A, Spada M, Ferreris S, et al. Dihydropteridine reductase deficiency in man: from biology to treatment. Med Res Rev 2004;24:127-150. (Pubitemid 38230677)
22. Sato K, Sumi-Ichinose C, Kai R, et al. Differential involvement of striosome and matrix dopamine system in a transgenic model of dopa-responsive dystonia. Proc Natl Acad Sci U S A 2008; 105:12551-12556.
23. Groenewegen HJ. Organization of the afferent connections of the mediodorsal thalamic nucleus in the rat, related to the mediodorsal-prefrontal topography. Neuroscience 1988;24: 379-431.
24. Sánchez-González MA, García-Cabezas MA, Rico B, et al. The primate thalamus is a key target for brain dopamine. J Neurosci 2005;25:6076-6083. (Pubitemid 40923474)
25. Ponzone A, Ferraris S, Biasetti S, et al. Placental barrier in mother-to-fetus transfer of tetrahydrobiopterin in humans. Unconjugated pterins and related biogenic amines. In: Curtius HC, Blau N, Leviev RA, eds. Berlin, Germany: Walter de Gruyter; 1987 pp. 219-292.
26. Ferre J, Naylor EW. Sepiapterin reductase in human amniotic and skin fibroblasts, chorionic villi, and various blood fractions. Clin Chim Acta 1988;174:271-282. (Pubitemid 18145293)
27. Derrick M, Drobyshevsky A, Ji X, Tan S. A model of cerebral palsy from fetal hypoxia-ischemia. Stroke 2007;38(2 suppl): 731-735. (Pubitemid 46184250)
28. Verbeek MM, Steenbergen-Spanjers GC, Willemsen MA, et al. Mutations in the cyclic adenosine monophosphate response element of the tyrosine hydroxylase gene. Ann Neurol 2007;62: 422-426.